NewEdge Wealth’s BlackRock Health Sciences Trust II BMEZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-28,940
Closed -$398K 1024
2025
Q2
$398K Sell
28,940
-13,750
-32% -$196K 0.01% 761
2025
Q1
$636K Hold
42,690
0.01% 576
2024
Q4
$615K Buy
42,690
+1,750
+4% +$27.1K 0.01% 599
2024
Q3
$648K Buy
40,940
+30,440
+290% +$480K 0.01% 567
2024
Q2
$161K Hold
10,500
﹤0.01% 737
2024
Q1
$156K Hold
10,500
﹤0.01% 781
2023
Q4
$154K Hold
10,500
﹤0.01% 719
2023
Q3
$151K Hold
10,500
﹤0.01% 626
2023
Q2
$172K Buy
+10,500
New +$171K 0.01% 614
2022
Q3
Sell
-32,227
Closed -$529K 528
2022
Q2
$529K Buy
+32,227
New +$553K 0.02% 382

Other funds holding BMEZ

NewEdge Wealth's BMEZ Position: Q3 2025 in Review

NewEdge Wealth sold out of BlackRock Health Sciences Trust II (BMEZ) in Q3 2025, closing a stake of 28,940 shares — an estimated $398K sold.

NewEdge Wealth first reported a position in BMEZ in Q2 2022 and held it in 10 quarters. The position peaked at $648K in Q3 2024. 77 funds tracked by Wall St. Rank hold BMEZ as of Q3 2025.

  • NewEdge Wealth reported no remaining BlackRock Health Sciences Trust II position as of Q3 2025 after selling out during the quarter.
  • NewEdge Wealth sold 28,940 BlackRock Health Sciences Trust II shares in Q3 2025, an estimated $398K.
  • NewEdge Wealth first reported a position in BlackRock Health Sciences Trust II in Q2 2022 and held it in 10 quarters.
  • NewEdge Wealth's BlackRock Health Sciences Trust II position peaked at $648K in Q3 2024.
  • 77 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust II as of Q3 2025.

Based on NewEdge Wealth's 13F filing for Q3 2025, filed 7 Nov 2025.